Content |
Depression
Main article: Depression
2024: 16.8% increase in sales of antidepressants in Russia to 16.1 million packages
The analytical company DSM Group in January 2025 reported that sales of antidepressants in Russia in 2024 reached 16.1 million packages, which is 16.8% higher than in 2023.
According to Kommersant, according to the Center for the Development of Advanced Technologies (CRPT), the operator of the Honest Sign labeling system, the demand for antidepressants in 2024 increased by 22%. At the same time, the total supply of drugs increased by 20% to 25.9 million packages.
Sales of antidepressants inAccording to data, in Rosstat 2024 the cost of medicines increased by 11% with a total of inflations 9.5%. Due to high demand and logistical problems, some demanded drugs periodically disappear from pharmacies.
Denis Krasilnikov, Deputy General Director for Commerce of the distributor of Protek Central Television Company, notes that the shortage of individual drugs is observed periodically, but there is no talk of a total shortage.
The commercial director of Rigla, Ilya Nikolaev, reported on possible isolated cases of drug defects. Victoria Presnyakova, director of the Association of Independent Pharmacies, confirmed the limited availability of some drugs.
A certain cultural phenomenon arose in the country: patients facing depressive states began to use "folk medicine" less and go to doctors more often, - said Nikolai Bespalov, Development Director of RNC Pharma. |
Psychiatrist Vyacheslav Filashikhin pointed out the presence of alternative drugs with similar active substances. According to RNC Pharma, 17.1 million packages of antidepressants were sold in January-November 2024.
Amitriptyline, Fluoxetine and Zoloft remain the best-selling antidepressants in Russia. The growth in demand for antidepressants began in March 2022 and continues to increase, despite periodic difficulties with the supply of individual drugs.[1]
2023: Antidepressant sales rise to 17m packs
At the end of 2023, sales of antidepressants in Russia amounted to approximately 17 million packages. For comparison, in 2022 this figure was estimated at 15 million units. Thus, year-on-year growth was at 13%, as stated in a study by DSM Group, the results of which were published in early March 2024.
The report notes that in 2021, Russians purchased about 11 million packages of antidepressants, and in 2020 - 9.6 million. That is, in the period from 2020 to 2023 inclusive, the demand for such drugs in the Russian Federation increased by about 77%. Psychiatrists associate such a significant increase with two key factors: these are the consequences of the COVID-19 coronavirus pandemic, as well as the current situation in the world - both geopolitically and economically. According to a survey by the Russian Academy of National Economy and Public Administration under the President of the Russian Federation (RANEPA), approximately 60% of Russians regularly experience anxiety. Moreover, 46.8% reported moderate anxiety, and 13.2% reported severe anxiety.
Antidepressants have become very popular. Many psychologists began to send their patients to neurologists, and they prescribe antidepressants. A lot of people with sleep disorders, anxiety. A psychotherapist cannot always cope with this, "Novye Izvestia quotes Elena Nevolina, executive director of the National Pharmaceutical Chamber Union. |
It is noted that at the beginning of 2024, the demand for antidepressants in Russia continued to grow. In particular, in January-February, the consumption of such drugs, according to the estimates of one of the pharmacy chains in Moscow, jumped by about 30% compared to the first two months of 2023. In January-February 2024, Russians spent about 4.32 billion rubles on antidepressants.[2]
2022
The Ministry of Health of the Russian Federation reported new side effects of antidepressants used in pregnancy. They cause postpartum bleeding
In early July 2022, it became known about the requirement of the Ministry of Health of the Russian Federation to make changes to the instructions for a number of drugs for the treatment of depression. This applies to citalopram, escitalopram, fluoxetine, milnacipran, fluvoxamine, paroxetine, sertraline and venlafaxine.
According to a letter from the Ministry of Health posted in the State Register of Medicines, Roszdravnadzor received information about the risk of postpartum bleeding associated with the use by pregnant women of antidepressants of the group of selective serotonin reuptake inhibitors (SSRIs), selective serotonin reuptake inhibitors and norepinephrine (SSRIs).
In this regard, the Ministry of Health recommends that the owners and manufacturers of antidepressants add the following sections to the instructions:
- In the section "Use during pregnancy and breastfeeding," include the following information: "Observation data indicate an increased (less than twice) risk of postpartum bleeding after the use of drugs of the SSRI/SSRI groups within one month before delivery."
- Section "Adverse Event" should be supplemented with the following information: "Postpartum hemorrhage * * *: frequency unknown (* * * This adverse event has been reported as a class effect in the SSRI/SSRI groups."
- Supplement the section "Special warnings" with the information: "Taking drugs of the SSRI/SSRI groups may increase the risk of postpartum bleeding."
The document states that the information is based on data from the European Regulator's Pharmacovigilance Risk Assessment Committee (PRAC EMA).
By the beginning of July 2022, more than 70 trade names of drugs of these groups are in civil circulation in Russia. However, not all of them have this information displayed in the instructions for use.[3]
Named Russian regions where antidepressants are more often taken
Residents, and more Moscow St. Petersburg Moscow region often than others, take antidepressants, according to a study that released a digital labeling system in May 2022. " Honest sign According to the report, every eighth resident of Moscow is treated for depression (1268 packages per 10 thousand people), St. Petersburg and every ninth in the Moscow region (1102 and 1158 packages, respectively). The top 5 also included (964 Kaluzhskaya) and (955 Rostovskaya region).
According to analysts, the most "happy" regions of Russia were Tuva, Chechnya and the Nenets Autonomous Okrug. In particular, about one out of 172 people takes antidepressants in Tuva (on average, 58 packages per 10 thousand people are bought), in Chechnya - every 120th (83 packages), in the Nenets Autonomous Okrug - every 70th (143 packages). Further in the ranking of "happy" regions are: the Republic of Sakha (147 packages), the Chukotka Autonomous Okrug (193), Buryatia (195), Kalmykia (200), Ingushetia (202), Dagestan and the Trans-Baikal Territory (206 packages each).
It is noted that in March 2022, sales of antidepressants increased significantly in Russia. The volume of sales of sedatives from February 28 to March 6 exceeded 525 million rubles, exceeding the indicators of a year ago by almost 4.5 times.
According to VTsIOM, which were released in April 2022, the number of people who consider themselves happy has decreased in Russia in six months. According to the center, in April, 83% of Russians called themselves happy. Of these, 37% called themselves definitely happy, rather happy - another 46%. 14% of respondents consider themselves unhappy to one degree or another, 4% found it difficult to answer.
According to a survey of the Doctor Near service and HeadHunter, by May 2022, every second Russian complained of an increase in stress. From the results of their study, it follows that 69% of Russians said that their stress level had increased, 52% noted that they became more nervous, and 17% of respondents had an increased level of anxiety, "but not critical."[4]